Xaar printhead used for personalized medicines

Added Scientific, a research company based in Nottingham, UK, has used Xaar’s 1201 printhead in a study to test the suitability of inkjet printing in the manufacture of personalised pharmaceutical pills, where dosages could be tailored to individuals on an industrial scale.

Added Scientific has used Xaar 1201 printheads to demonstrate the feasibility of inkjet printing personalised medicines.

Added Scientific was set up to develop cutting edge additive manufacturing solutions in areas such as printing glass and functional lattices for automotive components. So the company has essentially approached the manufacturing of pills as a 3D-printing problem, and used a material jetting approach. Xaar’s an obvious choice for this, having a 3D division based at Nottingham and actively working on material jetting. 

The pilot project, which also involved AstraZeneca, examined the long-term scalability and suitability of using inkjet printing to dispense the active pharmaceutical ingredient in the pills. Craig Sturgess, research manager for Added Scientific, explains: “Inkjet printing offers the ability to digitally control the printing with its precision placement of tiny droplets a few picolitres in size and the capability to place multiple materials to create complex multi-functional objects in 2D & 3D.”

He added: “Trial research carried out previously has shown that inkjet offers a real potential for printed medicines. This project was designed to answer questions pharmaceutical companies have around the suitability of inkjet printing in dispensing APIs at a scale that made both manufacturing and economic sense.”

Those questions include how this technique affects the active pharmaceutical ingredient, and what impact the formulations have on the printhead’s life,  as well as the printhead’s ability to operate in Good Manufacturing Practice (GMP) conditions. This was compared against data from conventional tablet manufacturing from AstraZeneca.

The research found that there were significant time-savings in unit process times from inkjet printing when compared to traditional manufacturing methods in production trials of 1000 dosage forms manufactured in batches of 100. The study also showed that 1201 didn’t affect the active pharmaceutical ingredient, and that there was no impact on the expected life of the printhead.

Sturgess concludes: “Our project has clearly shown that printing personalised medicines – with all their advantages of dose and design freedom – is no longer just a theory, but a scalable and economic reality for pharmaceutical companies and we look forward to extended trials to confirm these findings.”

The 1201 is a Thin Film Piezo printhead that’s manufactured using silicon Micro Electrical Mechanical System (MEMS) technology. It has 1280 nozzles, arranged in 4 rows for printing either 1 or 2 colours at 600 dpi, or 4 colours at 300 dpi native resolution. It produces a 27mm print swathe with 2.5pl drop volume and is suitable for use with eco-solvent, UV or aqueous inks. It’s quite small and relatively easy to integrate and has generally been sold as a cost-effective option for the wide format and textiles markets. 

Mike Seal, business development manager of Advanced Manufacturing at Xaar, commented: “This pilot project has demonstrated the Xaar 1201’s versatility for pharmaceuticals and how inkjet printing is proving itself to have the potential to drive innovation as well as efficiencies in many areas of 21st century life.”

The study takes the personalized concept to a whole new level! This project was funded under the Industrial Strategy Challenge Fund’s Medicines Manufacturing Challenge, with support from Innovate UK.

You can find more information on Xaar and the 1201 printhead at www.xaar.com, and on Added Scientific here.


Posted

in

,

by

Syndicate content

You can license the articles from Printing and Manufacturing Journal to reproduce in other publications. I generally charge around £150 per article but I’m open to discussing this for each title, particularly for publishers that want to use multiple stories. I can provide high res versions of images for print publications.

I’m used to working with overseas publishers and am registered for VAT with the UK’s HMRC tax authority but obviously won’t charge VAT to companies outside the UK. You can find further details and a licensing form from this page, or just contact me directly here.

Support this site

If you find the stories here useful then please consider making a donation to help fund Printing and Manufacturing Journal, either as a one-off or a repeat payment. Journalism is only really useful if it’s truly independent and this is the only such news source serving the print/ manufacturing sectors.

However, there are costs involved in travelling to cover events, as well as maintaining this site, not to mention the time that it takes to carry out research, check facts and interview people. So if you value this work, then please help to maintain it and keep it free to read.

Subscribe

Never miss a story – subscribe to Printing and Manufacturing Journal to receive an email notification every time an article is published here. It’s completely free of charge and you can cancel the subscription at any point without any hassle. There’s no need to provide any information other than an email address and subscribers details are not for sale so there’s no risk of any further marketing spam.

Related stories

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *